Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, or nootropic drugs, boost mental function and are used as performance enhancers. They work by stimulating the brain's neurotransmitters to enhance neuron communications, improving cognition and memory. These substances are particularly beneficial for treating neurodegenerative diseases like Alzheimer's disease where cognitive functions are compromised.

Acetylcholinesterase inhibitors improve memory and cognition in mild to moderate cases of Alzheimer's disease by increasing acetylcholine levels in the brain. However, they can induce unwanted cholinergic effects such as salivation, lacrimation, drowsiness, urinary retention, and bowel disorders, limiting their use in some patients.

Synaptic plasticity involves long-term potentiation and depression, induced by glutamate receptor activation and modulated by dopamine. Cognitive enhancers work on the principle of synaptic plasticity and altered circuit function to improve cognition. This mechanism allows the brain to strengthen or weaken neural connections, enhancing learning and memory.

Memantine, an NMDA antagonist, inhibits NMDA receptor-mediated excitotoxicity and limits neuronal calcium influx, preventing intracellular toxic levels. It is used in moderate to severe cases of Alzheimer's disease to protect neurons from damage caused by excessive glutamate signaling and excitatory neurotransmission.

Modafinil increases extracellular dopamine levels and glutamate release while inhibiting GABA release, making it useful for ADHD treatment and cognitive performance. Piracetam, a positive allosteric AMPA receptor modulator, helps improve memory and cognition through different receptor mechanisms and synaptic enhancement.

Misuse of cognitive enhancers can lead to tolerance, where higher doses are required to achieve the same effects, and in severe cases, addiction. Overuse can cause cognitive impairment and other health issues. These substances must be used responsibly under healthcare professional supervision to minimize risks of drug abuse and addiction.

CANTAB tests, a series of computer-based cognitive assessments, are often used to evaluate the effectiveness of cognitive enhancers. They measure various aspects of cognition, including attention, episodic memory, working memory, decision-making, and response control, providing objective data on cognitive improvement and brain function.